Sally Garnett
About
In The Last Decade
Sally Garnett
12 papers receiving 815 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 614
- Pulmonary and Respiratory Medicine 544
- Genetics 340
- Cancer Research 269
- Molecular Biology 147
Countries citing papers authored by Sally Garnett
This map shows the geographic impact of Sally Garnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Garnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Garnett more than expected).
Fields of papers citing papers by Sally Garnett
This network shows the impact of papers produced by Sally Garnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Garnett. The network helps show where Sally Garnett may publish in the future.
Co-authorship network of co-authors of Sally Garnett
This figure shows the co-authorship network connecting the top 25 collaborators of Sally Garnett. A scholar is included among the top collaborators of Sally Garnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Garnett. Sally Garnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 54 | |
| 4 | 23 | |
| 5 | 3 | |
| 6 | 17 | |
| 7 | 232 | |
| 8 | 16 | |
| 9 | 17 | |
| 10 | Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer breakdown → | 453 |
| 11 | 16 | |
| 12 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.